Healthcare Sales & Marketing Network News: Plasma Protein

Searching News Database: Plasma Protein

HSMN NewsFeed - 7 Aug 2020
Haemonetics Clinical Study Results On A New, Personalized Approach To Plasma Collection To Be Presented At 2020 AABB Annual Meeting
Devices

HSMN NewsFeed - 7 Oct 2016
Fresenius Kabi Receives FDA 510(k) Clearance for the Aurora(TM) Xi Plasmapheresis System
Devices FDA

HSMN NewsFeed - 27 Jul 2016
Pernix Therapeutics Announces Reorganization of Senior Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Feb 2015
FDA Approves New Dosing Option for CSL Behring's Hizentra(R)
Biopharmaceuticals FDA

HSMN NewsFeed - 21 Feb 2014
In a Subanalysis, Eliquis(R) (apixaban) Reduced the Risk of Stroke and Demonstrated Fewer Major Bleeding Events versus Warfarin Consistently across Age Groups, Including Older Patients with Nonvalvular Atrial Fibrillation
Biopharmaceuticals Cardiology

HSMN NewsFeed - 3 Sep 2013
CSL Behring Announces FDA Approval of a 10 g (50 mL) Vial Size for Hizentra(R)
Biopharmaceuticals FDA

HSMN NewsFeed - 3 Sep 2013
Subanalysis of Phase III ARISTOTLE Trial of Eliquis(R) (apixaban) Demonstrated Consistent Results Versus Warfarin in Patients with Nonvalvular Atrial Fibrillation with or without Valvular Heart Disease
Biopharmaceuticals Cardiology

HSMN NewsFeed - 28 Aug 2013
Grifols and Aradigm Corporation Complete the Closing of Worldwide Licensing Agreement to Develop and Commercialize Pulmaquin(R)
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 28 Feb 2013
CSL Behring Receives FDA Approval to Expand the Indication for Corifact(R)
Biopharmaceuticals Surgery FDA

HSMN NewsFeed - 7 Feb 2013
BioAegis Therapeutics Inc. Completes Initial $3 Million Raise
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 4 Oct 2012
Study Supports Efficacy, Safety of Hizentra(R) in Japanese Patients with Primary Immunodeficiency Disease
Biopharmaceuticals

HSMN NewsFeed - 27 Jun 2012
PRIMA Study Shows Treatment with Privigen(R) Improved Function in Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Biopharmaceuticals

HSMN NewsFeed - 15 Mar 2012
CSL Behring Announces First Patient Treated in Phase III Study of Fibrinogen Concentrate (Human)(FCH) to Control Bleeding During Aortic Aneurysm Surgery
Biopharmaceuticals Surgery

HSMN NewsFeed - 3 Jan 2012
CSL Behring Receives FDA Approval of Expanded Label on Berinert(R) for Self-administration and Treatment of Acute Laryngeal Attacks of Hereditary Angioedema
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 31 Aug 2011
Baxter Announces FDA Approval of ARTISS Fibrin Sealant for Use in Face-Lift (Facial Rhytidectomy) Procedures
Devices FDA

HSMN NewsFeed - 28 Feb 2011
Santarus and Pharming Announce Receipt of FDA Refusal to File Letter for RHUCIN Biologics License Application
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Feb 2011
Santarus and Pharming Announce Initiation of Phase IIIb Clinical Study with RHUCIN in Acute Hereditary Angioedema
Biopharmaceuticals

HSMN NewsFeed - 27 Jan 2011
CSL Behring Receives National Marketing Authorization of Berinert(R) in Israel
Biopharmaceuticals Regulatory

HSMN NewsFeed - 28 Dec 2010
Pharming and Santarus announce submission of Rhucin Biologics License Application to FDA
Biopharmaceuticals

HSMN NewsFeed - 28 Dec 2010
Pharming and Swedish Orphan Biovitrum announce first sales of Ruconest in Europe
Biopharmaceuticals

HSMN NewsFeed - 7 Oct 2010
Privigen(R) Demonstrates Efficacy and Tolerability Among Patients With Various Immunodeficiencies, Data Show
Biopharmaceuticals

HSMN NewsFeed - 7 Oct 2010
Data Support Hizentra(R) Efficacy, Safety After Dose-Equivalent Switch in Adult and Pediatric Patients with Primary Immunodeficiency
Biopharmaceuticals

HSMN NewsFeed - 7 Oct 2010
Study Demonstrates Safety and Efficacy of Subcutaneous Vivaglobin(R) as First-Line Therapy for Primary Immunodeficiency
Biopharmaceuticals

HSMN NewsFeed - 5 Oct 2010
RHUCIN Clinical Trial Data Published in the Journal of Allergy and Clinical Immunology
Biopharmaceuticals

HSMN NewsFeed - 13 Sep 2010
Pharming signs commercialization agreement with Santarus for Rhucin(R) in North America
Biopharmaceuticals

HSMN NewsFeed - 16 Jul 2010
GTC Biotherapeutics Regains US Rights to ATryn(R) ; the First Recombinant Antithrombin Product Approved in the World
Biopharmaceuticals

HSMN NewsFeed - 16 Jun 2010
GTC Biotherapeutics Announces New $7 Million Financing, Company Restructuring and Management Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Jun 2010
Grifols to Acquire Talecris Biotherapeutics Creating a World Leading Provider of Life-Saving Plasma Protein Therapies
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 26 Jan 2010
Prometheus Acquires Exclusive Rights to PROLEUKIN(R) (aldesleukin) in the U.S.
Biopharmaceuticals Oncology Acquisitions

HSMN NewsFeed - 13 Jan 2010
Octapharma Receives Orphan Drug Exclusivity Approval for wilate(R) - A Replacement Therapy Developed Specifically for von Willebrand Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 11 Jan 2010
ViroPharma Expands Global Licensing, Commercialization and Development Rights for Cinryze(TM) (C1 esterase inhibitor [human])
Biopharmaceuticals Licensing

HSMN NewsFeed - 7 Dec 2009
Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Oct 2009
CSL Behring Announces FDA Approval of Berinert(R), First and Only Therapy Approved for the Treatment of Acute Abdominal and Facial Attacks of Hereditary Angioedema in U.S.
Biopharmaceuticals FDA

HSMN NewsFeed - 28 Sep 2009
CSL Biotherapies Reaches Agreement with Merck & Co. on Rights to Market and Distribute Afluria(R) in the U.S.
Biopharmaceuticals Distribution

HSMN NewsFeed - 8 Jul 2009
GTC Biotherapeutics in-Licenses Recombinant Human Alpha-Fetoprotein from Merrimack Pharmaceuticals
Biopharmaceuticals Licensing

HSMN NewsFeed - 11 Mar 2009
CSL Behring Receives Orphan-Drug Exclusivity for RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency
Biopharmaceuticals FDA

HSMN NewsFeed - 13 Feb 2009
Haemacure Restructures - Seeks Financing or Sale of the Company
Biopharmaceuticals Devices Surgery Wound Care

HSMN NewsFeed - 3 Feb 2009
FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE)
Biopharmaceuticals FDA

HSMN NewsFeed - 17 Jan 2009
CSL Behring Receives FDA Approval of RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Jan 2009
Kawasaki Disease Treated with Plasma-Derived Therapy
Biopharmaceuticals

HSMN NewsFeed - 1 Oct 2008
Haemacure Appoints Thomas J. Lynch, J.D., Ph.D. to Board of Directors
Devices Personnel

HSMN NewsFeed - 8 Jul 2008
FDA Approves EOVIST(R) to Detect and Characterize Focal Liver Lesions
Biopharmaceuticals Radiology FDA

HSMN NewsFeed - 15 May 2008
Haemacure appoints Reinaldo M. Diaz to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 May 2008
Lev Pharmaceuticals Announces Cinryze(TM) Complete Response Submission Accepted for Review by FDA
Biopharmaceuticals FDA

HSMN NewsFeed - 2 May 2008
Lev Announces FDA Advisory Committee Unanimously Recommends Approval of Cinryze(TM) for Hereditary Angioedema
Biopharmaceuticals FDA

HSMN NewsFeed - 15 Apr 2008
Lev Pharmaceuticals Announces Submission of Complete Response to FDA for Cinryze(TM) for Hereditary Angioedema
Biopharmaceuticals

HSMN NewsFeed - 10 Apr 2008
Corgenix Announces FDA Clearance for IgG Anti-AtherOx(R) Test Kit
Diagnostics FDA

HSMN NewsFeed - 6 Mar 2008
CSL Behring Submits BLA Requesting Approval of C1-Esterase Inhibitor for the Treatment of Hereditary Angioedema
Biopharmaceuticals

HSMN NewsFeed - 25 Feb 2008
Last Patient Enrolled In ATryn(R) Pivotal Study
Biopharmaceuticals

HSMN NewsFeed - 11 Feb 2008
ACAAI Publishes New Supplement on Hereditary Angioedema
Biopharmaceuticals

HSMN NewsFeed - 10 Jan 2008
LFB Biotechnologies to Collaborate with GTC Biotherapeutics on Coagulation Factor IX Program
Biopharmaceuticals

HSMN NewsFeed - 19 Dec 2007
CSL Behring Expands Into Middle East Market with Haemate(R) P
Biopharmaceuticals

HSMN NewsFeed - 4 Dec 2007
Biotest Pharmaceuticals Corporation Completes Acquisition of Nabi Biologics Business Unit
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 4 Dec 2007
Biotest Pharmaceuticals Corporation Announces Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Nov 2007
CSL Behring Reaches Primary Endpoint in Clinical Study of C1-INH for Treatment of Hereditary Angioedema
Biopharmaceuticals

HSMN NewsFeed - 11 Sep 2007
Nabi Biopharmaceuticals Announces Sale of Nabi Biologics to Biotest AG
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 10 Sep 2007
Lev Pharmaceuticals Meets Primary Endpoint in Pivotal Phase III Prophylactic Trial for Hereditary Angioedema
Biopharmaceuticals

HSMN NewsFeed - 9 Aug 2007
Newly Created Hemosol BioPharma Inc. on the Hunt for Partnership, Licensing and Acquisition Targets
Biopharmaceuticals Licensing

HSMN NewsFeed - 31 Jul 2007
Lev Pharmaceuticals Submits Biologics License Application for Cinryze(TM)
Biopharmaceuticals FDA

HSMN NewsFeed - 30 Jul 2007
Corgenix Submits 510(k) Filing for IgG Anti-AtherOx(TM) Test Kit
Diagnostics FDA

HSMN NewsFeed - 9 Jul 2007
Peregrine Acquires Worldwide Rights to Novel Anti-Angiogenesis Technology From M. D. Anderson Cancer Center
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 27 Jun 2007
Beckman Coulter Grants Sublicense to Dade Behring for Novel Cardiac Markers
Diagnostics Licensing

HSMN NewsFeed - 31 May 2007
Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of C1-Esterase Inhibitor for Hereditary Angioedema
Biopharmaceuticals

HSMN NewsFeed - 29 May 2007
Dade Behring and Novation Sign Three-Year Agreement for Chemistry Instruments, Reagents
Diagnostics Group Purchasing

HSMN NewsFeed - 30 Apr 2007
Humate-P(R) Approved to Prevent Excessive Bleeding in Patients with von Willebrand Disease Undergoing Surgery
Biopharmaceuticals FDA

HSMN NewsFeed - 2 Apr 2007
FDA Approves Rhophylac(R) for the Treatment of Immune Thrombocytopenic Purpura (ITP)
Biopharmaceuticals FDA

HSMN NewsFeed - 13 Mar 2007
Kedrion and ProMetic Form Strategic Alliance to Develop Orphan Drugs from Plasma
Biopharmaceuticals

HSMN NewsFeed - 27 Feb 2007
Study Finds C1-Inhibitor Concentrate Is Safe and Effective in Treating Skin Swelling in Patients With Hereditary Angioedema
Biopharmaceuticals

HSMN NewsFeed - 1 Feb 2007
CSL Behring and Bayer Extend Agreement for Supply of Helixate(R) Recombinant Coagulation Factor
Biopharmaceuticals Licensing Distribution

HSMN NewsFeed - 8 Jan 2007
CSL Behring Reports Progress on Global Implementation of Name Change
Biopharmaceuticals

HSMN NewsFeed - 3 Jan 2007
ATryn(R) Market Authorization Transferred To LEO Pharma A/S
Biopharmaceuticals

HSMN NewsFeed - 20 Dec 2006
China Medical Successfully Develops Down Syndrome Diagnostic Reagents
Diagnostics

HSMN NewsFeed - 18 Dec 2006
ZLB Behring Completes Purchase of CytoGam(R) Immunoglobulin Therapy From MedImmune
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 11 Dec 2006
Clearant Announces Agreement to Expand Its Direct Distribution Growth Initiative (R) to the Sports Medicine Market in the New York Region
Devices Orthopaedic Distribution

HSMN NewsFeed - 2 Nov 2006
Enzon Pharmaceuticals Announces Second Investigational New Drug Application Approved for Novel rhMBL
Biopharmaceuticals FDA

HSMN NewsFeed - 11 Oct 2006
Baxter Announces Launch of BAXJECT(R) II Needle-Less Transfer Device for ADVATE(R)
Devices

HSMN NewsFeed - 2 Oct 2006
GTC Biotherapeutics and LFB Biotechnologies Enter Strategic Collaboration for Recombinant Plasma Proteins and Monoclonal Antibodies
Biopharmaceuticals

HSMN NewsFeed - 12 Sep 2006
Clearant Presents Patient Data at One Year Post Surgery Showing Complete Recovery of Range of Motion for Patients Implanted with Sterile Clearant Process(R) Tissue
Devices Orthopaedic

HSMN NewsFeed - 3 Aug 2006
Clearant Expands Addressable Market for Orthopedic Allograft Surgeries to Include Both Soft Tissue and Bone Implants
Devices Orthopaedic

HSMN NewsFeed - 11 Jul 2006
Clearant Gains Support for Clearant Process(R) Sterile Implants at the American Orthopaedic Society for Sports Medicine Annual Conference
Devices Orthopaedic

HSMN NewsFeed - 7 Jul 2006
Clearant Sterile Bone Implants Used for First Time in Successful Spinal Surgery at UCLA
Devices Neurosurgery Orthopaedic

HSMN NewsFeed - 24 May 2006
ProMetic Life Sciences Inc. Provides Update on PPPS Licensing Agreement with Hemosol
Biopharmaceuticals Licensing

HSMN NewsFeed - 9 May 2006
Baxter Receives FDA Approval for Ultra-High Dosage Strength of ADVATE for Hemophilia A
Biopharmaceuticals FDA

HSMN NewsFeed - 9 May 2006
Clearant Initiates Direct Sales Strategy, Enters Supplier Agreement
Devices

Return to NewsFeed

Additional items found! 61

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 61 additional stories matching:
Plasma Protein
(Password required)

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!